$7.170
+0.195 (+2.72%)At close
TVGN Comparative Benchmarking
In the context of the broader market, TVGN competes directly with industry leaders such as FLNA and BCTX. With a market capitalization of $43.95M, it holds a significant position in the sector. When comparing efficiency, TVGN's gross margin of N/A stands against FLNA's N/A and BCTX's N/A. Such benchmarking helps identify whether Tevogen Inc is trading at a premium or discount relative to its financial performance.
Tevogen Bio Holdings Inc Financial Performance
Tevogen has consistently reported negative net income, with the latest quarter showing a loss of -5,839,776 USD. The company has a current ratio of 0.33, indicating liquidity issues, and total equity remains negative at -8,888,760 USD.
Financials
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.